Thanks for highlighting that aspect, Krushingit. Cabotamig wasn't something I wanted to go delving too deep into, but now that you have raised the scenario, it looks as though I will have to rush off and buy some Arbele shares! Only joking!!!
There appear to be already a number of Bispecifics on the commercial market for the purpose of providing "maintenance" treatment for cancer sufferers.
This slide puts our CDH17 and CLTX targeted assets in perspective:-
Maybe Dr Durie could fill in for me!!!
CHM Price at posting:
3.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)